logo

Theravance, Inc. (THRX)



Trade THRX now with
  Date
  Headline
11/15/2021 7:13:53 AM Theseus Pharmaceuticals Q3 Net Loss Widens To $7.4 Mln From $1.4 Mln Last Year
11/1/2021 8:24:40 AM Wedbush Starts THERAVANCE, INC. (THRX) At Outperform With $24 Price Target
10/6/2021 10:37:01 PM Theseus Pharma Prices IPO Of 10.00 Mln Shares At $16.00/shr
8/6/2014 5:04:14 PM THERAVANCE, INC. (THRX) Declares $ 0.25 Dividend for Q3 14, Record Date 8/28/2014
8/1/2012 8:09:49 AM Robert W. Baird Is Raising THERAVANCE, INC. (THRX) FY12 Estimate To -0.30 From -0.33
5/1/2012 7:56:44 AM Robert W. Baird Is Increasing THERAVANCE, INC. (THRX) FY 13 Estimate To -1.11 From -1.26
5/1/2012 7:56:25 AM Robert W. Baird Is Lowering THERAVANCE, INC. (THRX) FY 12 Estimate To -0.33 From -0.32
2/10/2012 7:59:53 AM Robert W. Baird Is Increasing THERAVANCE, INC. (THRX) FY 12 Estimate To -0.32 From -1.32
1/9/2012 7:29:36 AM Robert W. Baird Is Lowering THERAVANCE, INC. (THRX) FY12 Estimate To -1.32 From -1.25
10/31/2011 7:40:50 AM Robert W. Baird Is Cutting THERAVANCE, INC. (THRX) FY11 Estimate To -1.35 From -1.33
7/29/2011 10:06:06 AM Robert W. Baird Is Raising THERAVANCE, INC. (THRX) FY 12 Estimate To -1.25 From -1.26
7/29/2011 10:05:49 AM Robert W. Baird Is Cutting THERAVANCE, INC. (THRX) FY 11 Estimate To -1.33 From -1.27
4/23/2009 10:49:09 AM Credit Suisse Is Lowering THERAVANCE, INC. (THRX) 2010 Estimate To -1.16 From -1.03